Stobdan Kalon

1.3k total citations
17 papers, 457 citations indexed

About

Stobdan Kalon is a scholar working on Infectious Diseases, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Stobdan Kalon has authored 17 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 12 papers in Epidemiology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Stobdan Kalon's work include Tuberculosis Research and Epidemiology (13 papers), Pneumonia and Respiratory Infections (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Stobdan Kalon is often cited by papers focused on Tuberculosis Research and Epidemiology (13 papers), Pneumonia and Respiratory Infections (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Stobdan Kalon collaborates with scholars based in South Africa, India and United Kingdom. Stobdan Kalon's co-authors include Helen Cox, Petros Isaakidis, Gabriella Ferlazzo, Sabine Rüsch–Gerdes, Homa Mansoor, Mrinalini Das, Chinmay Laxmeshwar, Zinaida Tigay, Erika Mohr-Holland and Catherine Hewison and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Lancet Infectious Diseases.

In The Last Decade

Stobdan Kalon

17 papers receiving 443 citations

Peers

Countries citing papers authored by Stobdan Kalon

Since Specialization

Citations

This map shows the geographic impact of Stobdan Kalon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stobdan Kalon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stobdan Kalon more than expected).

Fields of papers citing papers by Stobdan Kalon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stobdan Kalon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stobdan Kalon. The network helps show where Stobdan Kalon may publish in the future.

Co-authorship network of co-authors of Stobdan Kalon

This figure shows the co-authorship network connecting the top 25 collaborators of Stobdan Kalon. A scholar is included among the top collaborators of Stobdan Kalon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stobdan Kalon. Stobdan Kalon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study 2021 ·PLoS ONE ·Mrinalini Das, (unknown), (unknown), (unknown), (unknown), Homa Mansoor, Stobdan Kalon, Farah Hossain, (unknown), Gabriella Ferlazzo, Petros Isaakidis, Harshad Thakur	22
2	Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India 2021 ·PLoS ONE ·(unknown), Mrinalini Das, (unknown), (unknown), Daksha Shah, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Homa Mansoor, Stobdan Kalon, (unknown), Gabriella Ferlazzo, Petros Isaakidis, Harshad Thakur	16
3	Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India 2020 ·PLoS ONE ·Chinmay Laxmeshwar, (unknown), Mrinalini Das, (unknown), (unknown), (unknown), Preeti Mehta, (unknown), Homa Mansoor, Stobdan Kalon, Pramila Singh, (unknown), Gabriella Ferlazzo, Petros Isaakidis	19
4	Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges 2020 ·PLoS ONE ·(unknown), (unknown), Sharath Burugina Nagaraja, Pruthu Thekkur, Homa Mansoor, (unknown), (unknown), Pramila Singh, Stobdan Kalon, Mrinalini Das, Gabriella Ferlazzo, Petros Isaakidis	12
5	Adapting TB services during the COVID-19 pandemic in Mumbai, India 2020 ·The International Journal of Tuberculosis and Lung Disease ·(unknown), Letícia C. Rebello, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Homa Mansoor, Stobdan Kalon, Daniela Garone, Gabriella Ferlazzo, Petros Isaakidis	20
6	Yield of Systematic Longitudinal Screening of Household Contacts of Pre-Extensively Drug Resistant (PreXDR) and Extensively Drug Resistant (XDR) Tuberculosis Patients in Mumbai, India 2020 ·Tropical Medicine and Infectious Disease ·(unknown), Vivek Gupta, Pramila Singh, Madhur Verma, (unknown), (unknown), Homa Mansoor, Stobdan Kalon, Sriram Selvaraju, Mrinalini Das, Chinmay Laxmeshwar, Gabriella Ferlazzo, Petros Isaakidis	5
7	One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India 2020 ·Clinical Infectious Diseases ·Mrinalini Das, (unknown), Chinmay Laxmeshwar, (unknown), (unknown), (unknown), (unknown), (unknown), Pramila Singh, Homa Mansoor, Stobdan Kalon, Farah Hossain, Nathalie Lachenal, (unknown), Gabriella Ferlazzo, Petros Isaakidis	17
8	New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India 2020 ·The International Journal of Tuberculosis and Lung Disease ·Mrinalini Das, (unknown), Homa Mansoor, (unknown), (unknown), Ira Shah, (unknown), Stobdan Kalon, Farah Hossain, Gabriella Ferlazzo, Petros Isaakidis, Jennifer Furin, (unknown), Harshad Thakur	11
9	Genotyping and outcomes of presumptive second line ART failure cases switched to third line or maintained on second line ART in Mumbai, India 2019 ·PLoS ONE ·(unknown), Rafaël Van den Bergh, Khine Wut Yee Kyaw, Chinmay Laxmeshwar, Mrinalini Das, (unknown), (unknown), Homa Mansoor, Stobdan Kalon, Petros Isaakidis	4
10	‘Working to stay healthy’, health-seeking behaviour in Bangladesh’s urban slums: a qualitative study 2019 ·BMC Public Health ·(unknown), (unknown), (unknown), Aminur Rahman, Sadika Akhter, Stobdan Kalon, (unknown), Animesh Biswas	39
11	GeneXpert and Community Health Workers Supported Patient Tracing for Tuberculosis Diagnosis in Conflict-Affected Border Areas in India 2019 ·Tropical Medicine and Infectious Disease ·Mrinalini Das, (unknown), Srinivasa R. Rao, (unknown), Homa Mansoor, Stobdan Kalon, Farah Hossain, Gabriella Ferlazzo, Petros Isaakidis	8
12	Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study 2018 ·The Lancet Infectious Diseases ·Gabriella Ferlazzo, Erika Mohr-Holland, Chinmay Laxmeshwar, Catherine Hewison, Jennifer Hughes, Sylvie Jonckheere, Naira Khachatryan, (unknown), (unknown), Amir Shroufi, Stobdan Kalon, Helen Cox, Jennifer Furin, Petros Isaakidis	91
13	High burden of malaria and anemia among tribal pregnant women in a chronic conflict corridor in India 2017 ·Conflict and Health ·(unknown), Mrinalini Das, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Daniel Remartínez, Stobdan Kalon, (unknown), Martin De Smet, Petros Isaakidis	27
14	Results of Xpert^® MTB/RIF implementation in Kyrgyzstan 2017 ·The International Journal of Tuberculosis and Lung Disease ·(unknown), (unknown), Stobdan Kalon, (unknown), (unknown), (unknown), (unknown), KM Monirul Islam, (unknown)	8
15	Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study 2014 ·The International Journal of Tuberculosis and Lung Disease ·Elisabeth Sánchez-Padilla, (unknown), Stobdan Kalon, (unknown), Արմեն Հայրապետյան, Francis Varaine, Mathieu Bastard, Maryline Bonnet	41
16	Tuberculosis ethambutol resistance: Concordance between phenotypic and genotypic test results 2009 ·Tuberculosis ·(unknown), Helen Cox, Stobdan Kalon, (unknown), Sabine Rüsch–Gerdes, Stefan Niemann	32
17	Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures 2007 ·PLoS ONE ·Helen Cox, Stobdan Kalon, (unknown), (unknown), Zinaida Tigay, Sabine Rüsch–Gerdes, (unknown), (unknown), (unknown)	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact